News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
110,044 Results
Type
Article (5751)
Company Profile (7)
Press Release (104286)
Section
Business (32738)
Career Advice (96)
Deals (6221)
Drug Delivery (5)
Drug Development (12472)
Employer Resources (9)
FDA (2353)
Job Trends (1520)
News (55226)
Policy (5106)
Tag
Academia (357)
Adcomms (1)
Allergies (8)
Alliances (11854)
ALS (18)
Alzheimer's disease (172)
Antibody-drug conjugate (ADC) (17)
Approvals (2382)
Artificial intelligence (32)
Autoimmune disease (1)
Automation (3)
Bankruptcy (19)
Best Places to Work (1105)
BIOSECURE Act (2)
Biosimilars (24)
Biotechnology (12)
Bladder cancer (14)
Brain cancer (6)
Breast cancer (25)
Cancer (305)
Cardiovascular disease (10)
Career advice (97)
Career pathing (2)
CAR-T (8)
Cell therapy (35)
Clinical research (10364)
Collaboration (146)
Compensation (25)
Complete response letters (3)
COVID-19 (332)
CRISPR (4)
C-suite (33)
Cystic fibrosis (9)
Data (332)
Depression (4)
Diabetes (23)
Diagnostics (912)
Digital health (3)
Diversity, equity & inclusion (7)
Drug discovery (24)
Drug pricing (1)
Drug shortages (3)
Duchenne muscular dystrophy (18)
Earnings (10710)
Editorial (1)
Employer branding (2)
Employer resources (9)
Events (11554)
Executive appointments (89)
FDA (2566)
Fibrodysplasia Ossificans Progressiva (1)
Funding (97)
Gene editing (8)
Generative AI (2)
Gene therapy (30)
GLP-1 (87)
Government (475)
Grass and pollen (2)
Guidances (5)
Healthcare (1782)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (4)
Indications (4)
Infectious disease (344)
Inflammatory bowel disease (22)
Influenza (11)
Intellectual property (24)
Interviews (7)
IPO (2199)
Job creations (450)
Job search strategy (86)
Labor market (1)
Layoffs (21)
Legal (1245)
Liver cancer (16)
Lung cancer (45)
Lymphoma (20)
Management (1)
Manufacturing (60)
MASH (10)
Medical device (1466)
Medtech (1467)
Mergers & acquisitions (4140)
Metabolic disorders (61)
Multiple sclerosis (9)
NASH (2)
Neurodegenerative disease (12)
Neuropsychiatric disorders (1)
Neuroscience (266)
NextGen: Class of 2025 (551)
Non-profit (294)
Now hiring (2)
Obesity (28)
Opinion (14)
Ovarian cancer (16)
Pain (8)
Pancreatic cancer (12)
Parkinson's disease (31)
Partnered (4)
Patents (36)
Patient recruitment (15)
Peanut (1)
People (8682)
Pharmaceutical (4)
Phase I (3077)
Phase II (4439)
Phase III (3601)
Pipeline (186)
Policy (5)
Postmarket research (339)
Preclinical (1385)
Press Release (8)
Prostate cancer (14)
Psychedelics (2)
Radiopharmaceuticals (26)
Rare diseases (47)
Real estate (1046)
Recruiting (3)
Regulatory (3710)
Reports (8)
Research institute (289)
Resumes & cover letters (5)
RSV (2)
Schizophrenia (14)
Series A (20)
Series B (9)
Service/supplier (1)
Sickle cell disease (3)
Spinal muscular atrophy (12)
Sponsored (3)
Startups (676)
Stomach cancer (1)
Supply chain (11)
Tariffs (1)
Vaccines (44)
Venture capitalists (5)
Weight loss (9)
Women's health (1)
Date
Today (1)
Last 7 days (110)
Last 30 days (316)
Last 365 days (4462)
2025 (1371)
2024 (5002)
2023 (5963)
2022 (10758)
2021 (10112)
2020 (8589)
2019 (6333)
2018 (4926)
2017 (5626)
2016 (5335)
2015 (6571)
2014 (5030)
2013 (4075)
2012 (4399)
2011 (4685)
2010 (3996)
Location
Africa (133)
Alabama (2)
Arizona (18)
Arkansas (1)
Asia (22855)
Australia (2743)
California (725)
Canada (303)
China (208)
Colorado (23)
Connecticut (28)
Delaware (5)
Europe (18364)
Florida (110)
Georgia (12)
Idaho (5)
Illinois (32)
India (11)
Indiana (11)
Iowa (1)
Japan (86)
Kansas (11)
Louisiana (2)
Maine (6)
Maryland (120)
Massachusetts (461)
Michigan (7)
Minnesota (44)
Missouri (6)
Nebraska (2)
Nevada (4)
New Jersey (278)
New Mexico (1)
New York (192)
North Carolina (97)
Northern California (323)
Ohio (16)
Oklahoma (1)
Oregon (1)
Pennsylvania (98)
Puerto Rico (2)
Rhode Island (1)
South America (184)
South Carolina (1)
Southern California (294)
Tennessee (2)
Texas (56)
United States (2419)
Utah (29)
Virginia (31)
Washington D.C. (2)
Washington State (30)
Wisconsin (7)
110,044 Results for "lg chemical ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AVEO Oncology, an LG Chem company, Announces Three Poster Presentations at ASCO 2025 Annual Meeting
April 29, 2025
·
3 min read
Press Releases
LG Chem and Acies Bio Collaborate to Advance Sustainable Production of Chemicals
December 5, 2024
·
4 min read
Press Releases
ImPact Biotech Presents Updated Efficacy Data from Evaluation of Padeliporfin VTP in LG UTUC and Intermediate-Risk Prostate Cancer at AUA 2025
April 29, 2025
·
6 min read
Drug Development
LG Chem company and AVEO Oncology Announce LG Chem’s First Proprietary Anti-Cancer Compound enters Phase 1 Clinical Study, Dosing Initiated in the U.S.
LG Chem and AVEO Oncology, an LG Chem company, announced that it has enrolled the first patient in the United States for a Phase 1 clinical study of LB-LR1109, LG Chem’s first proprietary anti-cancer investigational drug candidate.
June 13, 2024
·
4 min read
Press Releases
New Long-Term Follow-Up Data from OPTIMA II Study of UGN-102 Demonstrates Median Duration of Response of Two Years in Patients with LG-IR-NMIBC
April 28, 2025
·
7 min read
Press Releases
AVEO Oncology, an LG Chem company, Presents Two Posters for Tivozanib at the 2025 ASCO GU Meeting
February 19, 2025
·
9 min read
Press Releases
New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational Treatment Did Not Adversely Affect Functionality, Symptom Burden, and Quality of Life in Patients with LG-IR-NMIBC
April 28, 2025
·
8 min read
Press Releases
UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
April 28, 2025
·
8 min read
Business
The Jackson Laboratory and LG AI Research partner to pioneer biomedical advancements
The Jackson Laboratory and LG AI Research signed a partnership agreement creating an alliance between JAX’s longstanding expertise in biomedical research and data analysis and LG’s AI research and product development prowess.
March 11, 2024
·
4 min read
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..
January 23, 2024
·
2 min read
1 of 11,005
Next
